<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="pnpla6-dis" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">pnpla6-dis</book-part-id>
      <title-group>
        <title><italic toggle="yes">PNPLA6-</italic>Related Disorders</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Synofzik</surname>
            <given-names>Matthis</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Department of Neurodegenerative Diseases<break/>Hertie Institute for Clinical Brain Research<break/>University of T&#x000fc;bingen<break/>T&#x000fc;bingen, Germany</aff>
          <email>matthis.synofzik@uni-tuebingen.de</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hufnagel</surname>
            <given-names>Robert B</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Division of Human Genetics<break/>Cincinnati Children&#x02019;s Hospital Medical Center<break/>Cincinnati, Ohio</aff>
          <email>robert.hufnagel@cchmc.org</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Z&#x000fc;chner</surname>
            <given-names>Stephan</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Dr John T Macdonald Foundation Department of Human Genetics<break/>John P Hussman Institute for Human Genomics<break/>University of Miami Miller School of Medicine<break/>Miami, Forida</aff>
          <email>szuchner@med.miami.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>9</day>
          <month>10</month>
          <year>2014</year>
        </date>
        <date date-type="updated">
          <day>11</day>
          <month>6</month>
          <year>2015</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="cdg-1a" document-type="chapter">PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>)</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="alpers" document-type="chapter"><italic toggle="yes">POLG</italic>-Related Disorders</related-object>
      <abstract id="pnpla6-dis.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">PNPLA6</italic>-related disorders span a phenotypic continuum characterized by variable combinations of cerebellar ataxia, upper motor neuron involvement manifesting as spasticity and/or brisk reflexes, chorioretinal dystrophy associated with variable degrees of reduced visual function, and hypogonadotropic hypogonadism (delayed puberty and lack of secondary sex characteristics), either in isolation or as part of anterior hypopituitarism (growth hormone, thyroid hormone, or gonadotropin deficiencies). Common but less frequent features are peripheral neuropathy (usually of axonal type manifesting as reduced distal reflexes, diminished vibratory sensation, and/or distal muscle wasting), hair anomalies (long eyelashes, bushy eyebrows, or scalp alopecia), short stature, and impaired cognitive functioning (learning disabilities in children and deficits in attention, visuospatial abilities, and recall in adults). Some of these features can occur in distinct clusters on the phenotypic continuum: Boucher-Neuh&#x000e4;user syndrome (cerebellar ataxia, chorioretinal dystrophy, and hypogonadotropic hypogonadism); Gordon Holmes syndrome (cerebellar ataxia, hypogonadotropic hypogonadism, and &#x02013; to a variable degree &#x02013; brisk reflexes); Oliver-McFarlane syndrome (trichomegaly, chorioretinal dystrophy, short stature, intellectual disability, and hypopituitarism); Laurence-Moon syndrome; and spastic paraplegia type 39 (SPG39) (upper motor neuron involvement, peripheral neuropathy, and sometimes reduced cognitive functioning and/or cerebellar ataxia).</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of a <italic toggle="yes">PNPLA6-</italic>related disorder is suspected on clinical and neuroimaging findings and confirmed by identification of biallelic pathogenic variants in <italic toggle="yes">PNPLA6.</italic></p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Management is symptomatic and individually tailored.</p>
          <list list-type="bullet">
            <list-item>
              <p>Ataxia: continuous training of speech and swallowing, fine-motor skills, gait, and balance</p>
            </list-item>
            <list-item>
              <p>Spasticity: interventions to improving strength and agility such as exercises, assistive walking devices and/or ankle-foot orthotics, drugs to reduce muscle spasticity</p>
            </list-item>
            <list-item>
              <p>Chorioretinal dystrophy: low vision aids when central acuity is reduced; involvement with agencies for the visually impaired re vocational training, mobility training, and skills for independent living</p>
            </list-item>
            <list-item>
              <p>Hypothyroidism: hormone replacement therapy as soon as identified</p>
            </list-item>
            <list-item>
              <p>Growth hormone deficiency: hormone replacement therapy during childhood and/or adolescence as indicated</p>
            </list-item>
            <list-item>
              <p>Hypogonadotropic hypogonadism: hormone replacement therapy at the expected time of puberty</p>
            </list-item>
          </list>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> A daily regimen of physical therapy to maintain and improve coordination, muscle strength, and gait; to reduce spasticity; and to prevent contractures.</p>
          <p><italic toggle="yes">Surveillance:</italic> Periodic evaluations (annually or as needed) by a neurologist, ophthalmologist and (if necessary) an endocrinologist to assess progression and develop treatment strategies.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Alcohol; obesity; inactive, sedentary lifestyle; exposure to medications or chemicals that exacerbate neuropathy.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">PNPLA6</italic>-related disorders are inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the <italic toggle="yes">PNPLA6</italic> pathogenic variants in the family have been identified.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="pnpla6-dis.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="pnpla6-dis.Tc" orientation="portrait" position="anchor">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_pnpla6-dis.Tc_1_1_1_1" valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">PNPLA6</italic>-Related Disorders: Included Phenotypes</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_pnpla6-dis.Tc_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Boucher-Neuh&#x000e4;user syndrome</p>
                    </list-item>
                    <list-item>
                      <p><italic toggle="yes">PNPLA6</italic>-related Gordon Holmes syndrome</p>
                    </list-item>
                    <list-item>
                      <p>Oliver-McFarlane syndrome</p>
                    </list-item>
                    <list-item>
                      <p><italic toggle="yes">PNPLA6</italic>-related Laurence-Moon syndrome</p>
                    </list-item>
                    <list-item>
                      <p>Spastic paraplegia type 39 (SPG39)</p>
                    </list-item>
                  </list>
                </td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="pnpla6-dis.Diagnosis">
        <title>Diagnosis</title>
        <p>Due to its highly heterogeneous nature, no formal diagnostic criteria have been established for <italic toggle="yes">PNPLA6</italic>-related disorders based on clinical findings alone. The diagnosis can only be established by molecular genetic testing.</p>
        <sec id="pnpla6-dis.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>A <italic toggle="yes">PNPLA6-</italic>related disorder should be suspected in individuals with a combination of two or more of the following clinical features:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Cerebellar ataxia</bold> starting before age 50 years and associated with cerebellar atrophy</p>
            </list-item>
            <list-item>
              <p><bold>Upper motor neuron involvement</bold> presenting as spasticity and/or brisk reflexes</p>
            </list-item>
            <list-item>
              <p><bold>Chorioretinal dystrophy</bold> starting before age 50 years and leading to variable degrees of reduced visual function, including blindness. The diagnosis of chorioretinal dystrophy may be established by ophthalmologic assessment, including visual acuity, visual field testing, fundoscopy, and optic coherence tomography (OCT) [<xref ref-type="bibr" rid="pnpla6-dis.REF.synofzik.2015.580">Synofzik et al 2015</xref>]. OCT can detect thinning of the retina, loss of layered retinal architecture, and effacement of the choriocapillaris and choroidal vessels. Autofluorescence photographs and fluorescein angiography provide supplementary diagnostic information by revealing hyper- and hypofluorescent regions of abnormal retinal pigment epithelium and the choriocapillaris.</p>
            </list-item>
            <list-item>
              <p><bold>Hypogonadotropic hypogonadism</bold> usually presenting in the first two decades of life</p>
            </list-item>
          </list>
          <p>Common, but less frequent features:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Anterior hypopituitarism.</bold> Deficiency of hormones made by the anterior pituitary can result in growth hormone deficiency and insufficient production of thyroid or sex hormones. Deficient thyroid hormone production can result in intellectual disability in infancy and childhood and poor growth in infancy, childhood, and adolescence. Growth hormone deficiency can lead to short stature in infancy, childhood, or adolescence. Insufficient sex hormone production can lead to hypogonadotropic hypogonadism (see above).</p>
            </list-item>
            <list-item>
              <p><bold>Peripheral neuropathy</bold> (usually of axonal type), presenting with reduced distal reflexes, diminished vibratory sensation, and/or distal muscle wasting</p>
            </list-item>
            <list-item>
              <p><bold>Impaired</bold>
<bold>cognitive functioning</bold> unrelated to hormone deficiency that can include learning disabilities in children [<xref ref-type="bibr" rid="pnpla6-dis.REF.yoon.2013.181">Yoon et al 2013</xref>] and deficits in attention, visuospatial abilities, and recall in adults</p>
            </list-item>
            <list-item>
              <p><bold>Hair anomalies</bold> (long eyelashes, bushy eyebrows, or scalp alopecia)</p>
            </list-item>
          </list>
          <p>Some of these features can occur in certain combinations, presenting in partly distinct/partly overlapping clusters on the phenotypic continuum of the <italic toggle="yes">PNPLA6-</italic>related disorders:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Boucher-Neuh&#x000e4;user syndrome.</bold> Cerebellar ataxia, chorioretinal dystrophy, and hypogonadotropic hypogonadism [<xref ref-type="bibr" rid="pnpla6-dis.REF.boucher.1969.507">Boucher &#x00026; Gibberd 1969</xref>]; high predictive value (75%) for an underlying <italic toggle="yes">PNPLA6</italic>-related disorder [<xref ref-type="bibr" rid="pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.tarnutzer.2015.194">Tarnutzer et al 2015</xref>]</p>
            </list-item>
            <list-item>
              <p><bold>Gordon Holmes syndrome.</bold> Cerebellar ataxia, hypogonadotropic hypogonadism, and (to a variable degree) brisk reflexes [<xref ref-type="bibr" rid="pnpla6-dis.REF.holmes.1907.466">Holmes 1907</xref>]</p>
            </list-item>
            <list-item>
              <p><bold>Oliver-McFarlane syndrome.</bold> Trichomegaly, chorioretinal dystrophy, and congenital or childhood hypopituitarism [<xref ref-type="bibr" rid="pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.kmoch.2015.5614">Kmoch et al 2015</xref>]</p>
            </list-item>
            <list-item>
              <p><bold>Laurence-Moon syndrome.</bold> Cerebellar ataxia, chorioretinal dystrophy, peripheral neuropathy, spastic paraplegia and congenital or childhood hypopituitarism. One family diagnosed with Laurence-Moon syndrome has been reported to have biallelic pathogenic variants in <italic toggle="yes">PNPLA6</italic> [<xref ref-type="bibr" rid="pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</xref>]. Several other people with the same phenotypic cluster and biallelic pathogenic variants in <italic toggle="yes">PNPLA6</italic> have been reported [<xref ref-type="bibr" rid="pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</xref>] and described to have &#x0201c;spastic Boucher-Neuh&#x000e4;user syndrome,&#x0201d; demonstrating the continuum of <italic toggle="yes">PNPLA6</italic>- associated phenotypic clusters.</p>
            </list-item>
            <list-item>
              <p><bold>Spastic paraplegia type 39 (SPG39).</bold> Upper motor neuron involvement and peripheral neuropathy, and sometimes reduced cognitive functioning and/or cerebellar ataxia [<xref ref-type="bibr" rid="pnpla6-dis.REF.rainier.2008.780">Rainier et al 2008</xref>]</p>
            </list-item>
            <list-item>
              <p><bold>Severe retinal dystrophy with atrophy</bold> associated with autism, reported in one child with biallelic pathogenic variants in <italic toggle="yes">PNPLA6</italic> [<xref ref-type="bibr" rid="pnpla6-dis.REF.kmoch.2015.5614">Kmoch et al 2015</xref>]. The child had been previously given a diagnosis of <related-object link-type="booklink" source-id="gene" document-id="lca" document-type="chapter">Leber congenital amaurosis</related-object> (LCA). Given the age of the affected individual, it is possible that further features of one of the above clinical diagnoses could develop with time.</p>
            </list-item>
          </list>
          <p>The full phenotypic spectrum of <italic toggle="yes">PNPLA6</italic>-related disorders and the predictive value of the clinical features for identifying an underlying <italic toggle="yes">PNPLA6</italic>-related disorder remain to be confirmed.</p>
        </sec>
        <sec id="pnpla6-dis.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of a <italic toggle="yes">PNPLA6-</italic>related disorder is established in a proband by detection of biallelic <italic toggle="yes">PNPLA6</italic> pathogenic variants in <italic toggle="yes">trans</italic> configuration (see <xref ref-type="table" rid="pnpla6-dis.T.summary_of_molecular_geneti">Table 1</xref>).</p>
          <p><bold>One genetic testing strategy</bold> is sequence analysis of <italic toggle="yes">PNPLA6,</italic> followed by deletion/duplication analysis if only one or no pathogenic variant is identified. One exonic duplication has been reported to date [<xref ref-type="bibr" rid="pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</xref>].</p>
          <p><bold>An alternative genetic testing strategy</bold> is use of a multi-gene sequencing panel that includes <italic toggle="yes">PNPLA6</italic> and other genes of interest (see <xref ref-type="sec" rid="pnpla6-dis.Differential_Diagnosis">Differential Diagnosis</xref>). Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time.</p>
          <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
          <table-wrap id="pnpla6-dis.T.summary_of_molecular_geneti" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in <italic toggle="yes">PNPLA6-</italic>Related Disorders</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_pnpla6-dis.T.summary_of_molecular_geneti_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_pnpla6-dis.T.summary_of_molecular_geneti_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_pnpla6-dis.T.summary_of_molecular_geneti_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_pnpla6-dis.T.summary_of_molecular_geneti_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">PNPLA6</italic>
                  </td>
                  <td headers="hd_h_pnpla6-dis.T.summary_of_molecular_geneti_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_pnpla6-dis.T.summary_of_molecular_geneti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;20 families reported to date</td>
                </tr>
                <tr>
                  <td headers="hd_h_pnpla6-dis.T.summary_of_molecular_geneti_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_pnpla6-dis.T.summary_of_molecular_geneti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1 reported to date&#x000a0;<sup>4</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="pnpla6-dis.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="pnpla6-dis" object-id="pnpla6-dis.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="pnpla6-dis.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
              </fn>
              <fn id="pnpla6-dis.TF.1.2">
                <label>2. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="pnpla6-dis.TF.1.3">
                <label>3. </label>
                <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="pnpla6-dis.TF.1.4">
                <label>4. </label>
                <p>An intragenic duplication of exons 14-20 in <italic toggle="yes">PNPLA6</italic> has been reported in one individual with Oliver-McFarlane syndrome [<xref ref-type="bibr" rid="pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="pnpla6-dis.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="pnpla6-dis.Clinical_Description">
          <title>Clinical Description</title>
          <p>In all affected individuals reported to date, features of the <italic toggle="yes">PNPLA6</italic>-related disorder manifested in the first two decades of life [<xref ref-type="bibr" rid="pnpla6-dis.REF.rainier.2011.19">Rainier et al 2011</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.yoon.2013.181">Yoon et al 2013</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.deik.2014.2411">Deik et al 2014</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.kmoch.2015.5614">Kmoch et al 2015</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.tarnutzer.2015.194">Tarnutzer et al 2015</xref>]. The initial findings include one or several of the following features: gait disturbance, visual impairment due to chorioretinal dystrophy or atrophy, anterior hypopituitarism, or delayed puberty/primary amenorrhea. Gait disturbance may precede visual impairment or anterior hypopituitarism; or, in contrast, gait disturbance may follow visual impairment or hypopituitarism up to 35 years later [<xref ref-type="bibr" rid="pnpla6-dis.REF.deik.2014.2411">Deik et al 2014</xref>]. Although the combination of the three most common findings (gait disturbance, visual impairment, and delayed puberty/primary amenorrhea) is highly indicative of an underlying <italic toggle="yes">PNPLA6</italic>-related disorder, no single feature is specific or obligatory.</p>
          <p>Given the limited number of individuals reported to date and the lack of longitudinal studies of affected individuals, a more detailed understanding of the natural history of <italic toggle="yes">PNPLA6</italic>-related disorders remains to be determined.</p>
          <p>Gait disturbance is due to <bold>ataxia, spasticity (with or without paresis), peripheral neuropathy</bold>, or a combination thereof. Progression of the gait disturbance varies: more severely affected individuals lose the ability to walk without aid between ages 25 and 50 years and may become wheelchair dependent at this stage [<xref ref-type="bibr" rid="pnpla6-dis.REF.rainier.2011.19">Rainier et al 2011</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</xref>]; less affected individuals are still able to walk unaided at age 54 years [<xref ref-type="bibr" rid="pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</xref>].</p>
          <p><bold>Peripheral</bold>
<bold>neuropathy</bold>, if present, is usually of the axonal motor type, including an additional sensory component (sensorimotor neuropathy) reported to date in only three cases [Author, unpublished observation]. The motor neuropathy can be associated with severe atrophy of distal muscles, in particular the distal leg and intrinsic hand muscles, starting in the late teens [<xref ref-type="bibr" rid="pnpla6-dis.REF.rainier.2011.19">Rainier et al 2011</xref>]. Impairment of the sensory tracts (peripheral sensory neurons, dorsal columns) including diminished vibration sense and touch has been reported in different age groups [<xref ref-type="bibr" rid="pnpla6-dis.REF.rainier.2011.19">Rainier et al 2011</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.kmoch.2015.5614">Kmoch et al 2015</xref>].</p>
          <p>Functional impairment due to <bold>upper motor neuron involvement</bold> varies: while some affected individuals show only increased reflexes or extensor plantar responses, others have severe spastic paraparesis of the lower extremities [<xref ref-type="bibr" rid="pnpla6-dis.REF.rainier.2011.19">Rainier et al 2011</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</xref>]. Electrophysiologic data available are currently insufficient to determine whether corticospinal tract involvement is axonal (with motor evoked potentials showing almost normal central motor conduction times) or demyelinating (with motor evoked potentials showing severely prolonged central motor conduction times).</p>
          <p>Progressive <bold>visual impairment</bold>, which is less frequent than gait disturbances in the <italic toggle="yes">PNPLA6</italic>-related disorders, is typically due to chorioretinal dystrophy that is usually characterized by diffuse atrophy of choroidal vessels and retinal pigment epithelium on fundoscopy, leading to complete loss of the choriocapillaris layer and the retinal pigment epithelium [<xref ref-type="bibr" rid="pnpla6-dis.REF.deik.2014.2411">Deik et al 2014</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.synofzik.2015.580">Synofzik et al 2015</xref>], including death of photoreceptors and retinal thinning accompanied by lipofuscin metabolism abnormalities [<xref ref-type="bibr" rid="pnpla6-dis.REF.kmoch.2015.5614">Kmoch et al 2015</xref>]. Initially these deficits can present in the first few years of life with nystagmus, choroidal and retinal pigment atrophy, and bitemporal central visual field defects and blind spot enlargement. Visual acuity is often severely reduced (to perception of hand motion) such that some affected individuals meet the criteria for legal blindness in adolescence or adulthood [<xref ref-type="bibr" rid="pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.synofzik.2015.580">Synofzik et al 2015</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.kmoch.2015.5614">Kmoch et al 2015</xref>].</p>
          <p><bold>Anterior hypopituitarism</bold> manifests either in infancy or childhood (micropenis, cryptorchidism, thyroid and growth hormone deficiency) or in adolescence (hypogonadotropic hypogonadism and growth hormone deficiency) [<xref ref-type="bibr" rid="pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</xref>]. Congenital hypothyroidism and growth hormone deficiency can result in global developmental delay, severe cognitive impairment, and short stature. Hypogonadotropic hypogonadism usually becomes manifest during the second decade of life with delayed puberty and lack of secondary sexual characteristics including primary amenorrhea, small penis and testes, and absent pubic hair and/or breast development. These hormone deficiencies are responsive to hormone replacement therapy.</p>
          <p><bold>Cognitive functioning</bold> appears to be impaired in many (albeit not all) individuals with a <italic toggle="yes">PNPLA6</italic>-related disorder, including learning disabilities in children [<xref ref-type="bibr" rid="pnpla6-dis.REF.yoon.2013.181">Yoon et al 2013</xref>] and deficits in attention, visuospatial abilities, and recall in adults. Cognitive disability may be related to hypothyroidism in certain but not all individuals with biallelic pathogenic variants in <italic toggle="yes">PNPLA6</italic>.</p>
          <p><bold>Neuroimaging</bold> has shown the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Cerebellar atrophy in approximately 90% of all affected individuals [<xref ref-type="bibr" rid="pnpla6-dis.REF.rainier.2011.19">Rainier et al 2011</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.yoon.2013.181">Yoon et al 2013</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</xref>]</p>
            </list-item>
            <list-item>
              <p>Small pituitary in 20%-30% of all affected individuals [<xref ref-type="bibr" rid="pnpla6-dis.REF.yoon.2013.181">Yoon et al 2013</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</xref>]</p>
            </list-item>
            <list-item>
              <p>Thoracic cord atrophy in one individual [<xref ref-type="bibr" rid="pnpla6-dis.REF.rainier.2011.19">Rainier et al 2011</xref>]</p>
            </list-item>
          </list>
        </sec>
        <sec id="pnpla6-dis.GenotypePhenotype_Correlation">
          <title>Genotype-Phenotype Correlations</title>
          <p>No obvious genotype-phenotype correlation exists. It has been suggested that different biallelic pathogenic variants could lead to different dose-dependent reductions in hydrolysis activity of the neuropathy target esterase (NTE), with more severe reductions leading to more severe and early-onset phenotypes [<xref ref-type="bibr" rid="pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</xref>]. However, this hypothesis warrants further confirmation from larger genotype-phenotype studies, in particular given the fact that the same <italic toggle="yes">PNPLA6</italic> pathogenic variant can lead to different presentations (e.g., ataxia plus hypogonadism in one individual, and spastic ataxia in another) and to different degrees and progression rates of manifestation (e.g., loss of ambulation in a 44-year-old with a 17-year history of ataxia vs. full ambulation in a 42-year-old with a 36-year history of ataxia) [<xref ref-type="bibr" rid="pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</xref>]. Correspondingly, manifestations and disease progression differ not only between but also within families.</p>
          <p>Nor does the phenotype appear to depend on either the location of the pathogenic variant (e.g., mutation of the functionally important phospholipid esterase domain can present with a severe Oliver-McFarlane or Boucher-Neuh&#x000e4;user syndrome as well as with relatively mild spastic paraplegia; pathogenic variants occurring outside the esterase domain have been associated with Boucher-Neuh&#x000e4;user syndrome, Oliver-McFarlane syndrome, and severe retinal dystrophy with atrophy and autism) or the pathogenic variant type (e.g., both missense and frameshift variants have been reported with severe Oliver-McFarlane or Boucher-Neuh&#x000e4;user syndrome as well as with mild spastic ataxia) [<xref ref-type="bibr" rid="pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.kmoch.2015.5614">Kmoch et al 2015</xref>].</p>
        </sec>
        <sec id="pnpla6-dis.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance appears to be complete in individuals with biallelic <italic toggle="yes">PNPLA6</italic> pathogenic variants.</p>
        </sec>
        <sec id="pnpla6-dis.Prevalence">
          <title>Prevalence</title>
          <p><italic toggle="yes">PNPLA6</italic>-related disorders are rare in unselected neurologic populations. <xref ref-type="bibr" rid="pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al [2014a]</xref> identified two affected persons in 538 unrelated individuals with ataxia, spastic paraplegia, and/or neuropathy.</p>
          <p>In contrast, mutation of <italic toggle="yes">PNPLA6</italic> is common in Boucher-Neuh&#x000e4;user syndrome and Oliver-McFarlane syndrome: individuals in four of six families with Boucher-Neuh&#x000e4;user syndrome and 11 of 12 families with Oliver-McFarlane syndrome had biallelic pathogenic variants in <italic toggle="yes">PNPLA6</italic> [<xref ref-type="bibr" rid="pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.kmoch.2015.5614">Kmoch et al 2015</xref>]. Given that clinical descriptions of more than 30 index cases with Boucher-Neuh&#x000e4;user or Oliver-McFarlane syndromes have been reported to date, the number of individuals with this phenotype who are found to have biallelic <italic toggle="yes">PNPLA6</italic> pathogenic variants is likely to increase soon.</p>
        </sec>
      </sec>
      <sec id="pnpla6-dis.Genetically_Related_Allelic_D">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with mutation of <italic toggle="yes">PNPLA6</italic>.</p>
      </sec>
      <sec id="pnpla6-dis.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <sec id="pnpla6-dis.Disorders_with_Ataxia">
          <title>Disorders with Ataxia</title>
          <p><bold>Ataxia with hypogonadism and dementia.</bold> In contrast to <italic toggle="yes">RNF216/OTUD4</italic>-associated ataxia-hypogonadism, <italic toggle="yes">PNPLA6</italic>-related disorders are not typically accompanied by dementia. Biallelic mutation of <italic toggle="yes">RNF216</italic> or, in one family, biallelic pathogenic variants in both <italic toggle="yes">RNF216</italic> and <italic toggle="yes">OTUD4</italic>, are causative [<xref ref-type="bibr" rid="pnpla6-dis.REF.margolin.2013.1992">Margolin et al 2013</xref>].</p>
          <p><bold>Autosomal recessive spinocerebellar ataxia 16</bold>
<bold>(SCAR16)</bold> is characterized by ataxia with cerebellar atrophy and, to a variable degree, cognitive impairment, hypogonadism, and/or pyramidal tract involvement [<xref ref-type="bibr" rid="pnpla6-dis.REF.shi.2014.1013">Shi et al 2014</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.synofzik.2014b.57">Synofzik et al 2014b</xref>]. While phenotypic overlap exists, <italic toggle="yes">PNPLA6</italic>-related disorders are characterized by more rapid disease progression, and (unlike SCAR16), they include chorioretinal dystrophy. Biallelic pathogenic variants in <italic toggle="yes">STUB1</italic> (<italic toggle="yes">CHIP</italic>) are causative. See <related-object link-type="booklink" source-id="gene" document-id="ataxias" document-type="chapter">Hereditary Ataxia Overview</related-object>.</p>
          <p><related-object link-type="booklink" source-id="gene" document-id="pol3-leuk" document-type="chapter"><bold>Ataxia with hypogonadotropic hypogonadism, dental abnormalities and hypomyelinating leukodystrophy</bold></related-object><bold>.</bold> In contrast to this disorder, <italic toggle="yes">PNPLA6</italic>-related disorders are not associated with dental abnormalities or leukodystrophy. Biallelic pathogenic variants in <italic toggle="yes">POLR3A</italic> or <italic toggle="yes">POLR3B</italic> are causative [<xref ref-type="bibr" rid="pnpla6-dis.REF.daoud.2013.194">Daoud et al 2013</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.synofzik.2013a.e145">Synofzik et al 2013a</xref>].</p>
          <p><related-object link-type="booklink" source-id="gene" document-id="mss" document-type="chapter"><bold>Marinesco-Sj&#x000f6;gren syndrome</bold></related-object> is characterized by cerebellar ataxia with cerebellar atrophy, early-onset cataracts, mild to severe intellectual disability, hypotonia, muscle weakness, and hypergonadotropic hypogonadism due to biallelic pathogenic variants in <italic toggle="yes">SIL1</italic>. Marinesco-Sj&#x000f6;gren syndrome is invariably associated with the combination of a cerebellar syndrome, chronic myopathy, and cataracts after age seven years [<xref ref-type="bibr" rid="pnpla6-dis.REF.krieger.2013.3634">Krieger et al 2013</xref>]; myopathy and cataracts have not been reported in <italic toggle="yes">PNPLA6</italic>-related disorders. Biallelic mutation of <italic toggle="yes">SIL1</italic> is causative.</p>
          <p><bold>Ataxia with hypergonadotropic hypogonadism due to coenzyme Q<sub>10</sub> deficiency.</bold> In contrast to coenzyme Q<sub>10</sub> deficiency, <italic toggle="yes">PNPLA6</italic>-related disorders may present with hypogonadotropic hypogonadism, and are not known to be associated with CoQ<sub>10</sub> deficiency. See <related-object link-type="booklink" source-id="gene" document-id="ataxias" document-type="chapter">Hereditary Ataxia Overview</related-object>.</p>
          <p><related-object link-type="booklink" source-id="gene" document-id="sca-io" document-type="chapter"><bold>Infantile-onset spinocerebellar ataxia</bold></related-object>
<bold>(IOSCA)</bold> is a severe, progressive neurodegenerative disorder characterized by normal development until age one year, followed by onset of ataxia, muscle hypotonia, loss of deep-tendon reflexes, and athetosis. By adolescence, hypergonadotropic hypogonadism in females becomes evident. In contrast to <italic toggle="yes">PNPLA6</italic>-related disorders, IOSCA usually starts in early childhood and is mostly accompanied by athetosis, deafness, ophthalmoplegia, and/or epilepsy. Biallelic pathogenic variants in <italic toggle="yes">TWNK</italic> (previously <italic toggle="yes">C10orf2</italic>) are causative.</p>
          <p><bold>Abetalipoproteinemia (Bassen-Kornzweig syndrome)</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/200100">200100</ext-link>). and <bold>familial</bold>
<bold>hypobetalipoproteinemia</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/615558">615558</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/605019">605019</ext-link>) present with retinitis pigmentosa, progressive ataxia, steatorrhea, demyelinating neuropathy, dystonia, extrapyramidal signs, and spastic paraparesis (rare). Hypocholesterolemia and reduced lipid-soluble vitamins in serum are due to defective intestinal absorption of lipids. Biallelic pathogenic variants in <italic toggle="yes">MTP</italic> are causative of abetalipoproteinemia. Mutation of <italic toggle="yes">APOB</italic> or <italic toggle="yes">ANGPTL3</italic> causes familial hypobetalipoproteinemia.</p>
          <p><related-object link-type="booklink" source-id="gene" document-id="narp" document-type="chapter"><bold>Neurogenic muscle weakness, ataxia, and retinitis pigmentosa</bold></related-object> (NARP) is a childhood-onset disease most often characterized by proximal neurogenic muscle weakness with sensory neuropathy, ataxia, learning difficulties, and pigmentary retinopathy. Mutation of the mitochondrial DNA gene <italic toggle="yes">MT-ATP6</italic> is causative.</p>
          <p><related-object link-type="booklink" source-id="gene" document-id="refsum" document-type="chapter"><bold>Refsum disease</bold></related-object> is characterized by anosmia (a universal finding) and early-onset retinitis pigmentosa with variable combinations of chronic polyneuropathy, deafness, cerebellar ataxia, and ichthyosis. Cardiac conduction disorders are common. Serum concentration of phytanic acids is increased as their degradation is impeded by the underlying genetic defect. Biallelic pathogenic variants in <italic toggle="yes">PHYH</italic> or <italic toggle="yes">PEX7</italic> are causative.</p>
          <p><related-object link-type="booklink" source-id="gene" document-id="sca7" document-type="chapter"><bold>Spinocerebellar ataxia type 7</bold></related-object> is characterized by progressive cerebellar ataxia, including dysarthria and dysphagia, and a cone-rod retinal dystrophy with progressive central visual loss resulting in blindness in affected adults. Onset in early childhood or infancy has an especially rapid and aggressive course often associated with failure to thrive and regression of motor milestones. Expansion of a CAG trinucleotide repeat in <italic toggle="yes">ATXN7</italic> is causative.</p>
          <p><related-object link-type="booklink" source-id="gene" document-id="aved" document-type="chapter"><bold>Ataxia with vitamin E deficiency</bold></related-object>
<bold>(AVED)</bold> presents with early-onset progressive ataxia, clumsiness of the hands, loss of proprioception (especially of vibration and joint position sense), and areflexia. The principal criterion for diagnosis of AVED is a Friedreich ataxia-like neurologic phenotype combined with markedly reduced plasma vitamin E (&#x003b1;-tocopherol) concentration in the absence of known causes of malabsorption. Biallelic pathogenic variants in <italic toggle="yes">TTPA</italic> are causative.</p>
          <p><related-object link-type="booklink" source-id="gene" document-id="spg20" document-type="chapter"><bold>Troyer syndrome</bold></related-object> is characterized by progressive spastic paraparesis, dysarthria, pseudobulbar palsy, distal amyotrophy, motor and cognitive delays, short stature, and subtle skeletal abnormalities. Biallelic pathogenic variants in <italic toggle="yes">SPART</italic> are causative.</p>
          <p>See also <related-object link-type="booklink" source-id="gene" document-id="ataxias" document-type="chapter">Hereditary Ataxia Overview</related-object>.</p>
        </sec>
        <sec id="pnpla6-dis.Chorioretinal_Dystrophy">
          <title>Chorioretinal Dystrophy</title>
          <p><related-object link-type="booklink" source-id="gene" document-id="lca" document-type="chapter"><bold>Leber congenital amaurosis</bold></related-object>
<bold>(LCA),</bold> a severe dystrophy of the retina, typically becomes evident in the first year of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia, and keratoconus. Visual acuity is rarely better than 20/400. A characteristic finding is Franceschetti's oculo-digital sign, comprising eye poking, pressing, and rubbing. The appearance of the fundus is extremely variable. While the retina may initially appear normal, a pigmentary retinopathy reminiscent of retinitis pigmentosa is frequently observed later in childhood. The electroretinogram (ERG) is characteristically "nondetectable" or severely subnormal. Pathogenic variants in 17 genes are known to cause LCA: <italic toggle="yes">GUCY2D</italic> (locus: LCA1), <italic toggle="yes">RPE65</italic> (LCA2), <italic toggle="yes">SPATA7</italic> (LCA3), <italic toggle="yes">AIPL1</italic> (LCA4), <italic toggle="yes">LCA5</italic> (LCA5), <italic toggle="yes">RPGRIP1</italic> (LCA6), <italic toggle="yes">CRX</italic> (LCA7), <italic toggle="yes">CRB1</italic> (LCA8), <italic toggle="yes">NMNAT1</italic> (LCA9), <italic toggle="yes">CEP290</italic> (LCA10), <italic toggle="yes">IMPDH1</italic> (LCA11), <italic toggle="yes">RD3</italic> (LCA12), <italic toggle="yes">RDH12</italic> (LCA13), <italic toggle="yes">LRAT</italic> (LCA14)<italic toggle="yes">, TULP1</italic> (LCA15)<italic toggle="yes">, KCNJ13</italic> (LCA16), and <italic toggle="yes">IQCB1</italic>. Together, pathogenic variants in these genes are estimated to account for more than half of all LCA diagnoses. LCA is most often inherited in an autosomal recessive manner, with the exception of LCA due to heterozygous pathogenic variants in <italic toggle="yes">CRX</italic>, which is inherited in an autosomal dominant manner.</p>
          <p>See also <related-object link-type="booklink" source-id="gene" document-id="rp-overview" document-type="chapter">Retinitis Pigmentosa Overview</related-object>.</p>
        </sec>
        <sec id="pnpla6-dis.Other_Types_of_Disorders">
          <title>Other Types of Disorders</title>
          <p><bold>Multi-system mitochondrial diseases</bold> with retinopathy. See <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial Disorders Overview</related-object>.</p>
          <p><bold>Peripheral neuropathies</bold> with additional multi-system disease, including retinopathies. See <related-object link-type="booklink" source-id="gene" document-id="cmt" document-type="chapter">Charcot-Marie-Tooth Hereditary Neuropathy Overview</related-object>.</p>
          <p><bold>Complicated hereditary spastic paraplegias.</bold> See <related-object link-type="booklink" source-id="gene" document-id="hsp" document-type="chapter">Hereditary Spastic Paraplegia Overview</related-object>.</p>
        </sec>
      </sec>
      <sec id="pnpla6-dis.Management">
        <title>Management</title>
        <sec id="pnpla6-dis.Evaluations_Following_Initial">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with a <italic toggle="yes">PNPLA6</italic>-related disorder, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>MRI of the cerebrum (including the pituitary), cerebellum, and spinal cord (including the thoracic cord) to establish the extent of atrophy in the different brain regions and exclude other secondary causes for the clinical features</p>
            </list-item>
            <list-item>
              <p>Nerve conduction studies and EMG to determine the presence and extent of peripheral neuropathy</p>
            </list-item>
            <list-item>
              <p>Neuropsychological investigation, including IQ, attention span, visuospatial abilities, and recall</p>
            </list-item>
            <list-item>
              <p>If not performed at the time of diagnosis, ophthalmologic assessment, including visual acuity, visual field testing, fundoscopy, and optic coherence tomography (OCT) [<xref ref-type="bibr" rid="pnpla6-dis.REF.synofzik.2015.580">Synofzik et al 2015</xref>]. OCT can detect thinning of the retina, loss of layered retinal architecture, and effacement of the choriocapillaris and choroidal vessels. Autofluorescence photographs and fluorescein angiography provide supplementary diagnostic information by revealing hyper- and hypofluorescent regions of abnormal retinal pigment epithelium and the choriocapillaris.</p>
            </list-item>
            <list-item>
              <p>If not performed at the time of diagnosis, endocrinologic assessment for evidence of hypothyroidism, growth hormone deficiency, and hypogonadotropic hypogonadism. Hypogonadotropic hypogonadism is detected by decreased rise of gonadotropin levels (LH, FSH) in response to gonadotropin releasing hormone (GnRH). (See <related-object link-type="booklink" source-id="gene" document-id="kms" document-type="chapter">Isolated Gonadotropin-Releasing Hormone Deficiency</related-object> for more details about evaluation.)</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="pnpla6-dis.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>No disease-modifying drug treatment exists for <italic toggle="yes">PNPLA6</italic>-related disorders. Given the great phenotypic variability and broad spectrum of the disorders, management of symptoms must be individually tailored.</p>
          <p><bold>Ataxia.</bold> Management should be directed to providing continuous training in the form of active speech, fine-motor, and gait exercises [<xref ref-type="bibr" rid="pnpla6-dis.REF.fonteyn.2014.251">Fonteyn et al 2014</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.ilg.2014.248">Ilg et al 2014</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.synofzik.2014">Synofzik &#x00026; Ilg 2014</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Daily regimen with physiotherapy exercises focusing on active, physically demanding tasks [<xref ref-type="bibr" rid="pnpla6-dis.REF.ilg.2009.1823">Ilg et al 2009</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.ilg.2010.2239">Ilg et al 2010</xref>]</p>
            </list-item>
            <list-item>
              <p>Videogame-based whole-body training (&#x0201c;exergames&#x0201d;) with specific videogames aiming to improve coordination and rapid adaptation to changing environments [<xref ref-type="bibr" rid="pnpla6-dis.REF.ilg.2012.2056">Ilg et al 2012</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.synofzik.2013b.2656">Synofzik et al 2013b</xref>]</p>
            </list-item>
            <list-item>
              <p>Speech therapy [<xref ref-type="bibr" rid="pnpla6-dis.REF.sapir.2003.387">Sapir et al 2003</xref>]</p>
            </list-item>
            <list-item>
              <p>Swallowing therapy</p>
            </list-item>
          </list>
          <p><bold>Spasticity.</bold> Management should be directed to improving balance, strength, and agility:</p>
          <list list-type="bullet">
            <list-item>
              <p>Daily regimen with physiotherapy exercises focusing on improving muscle strength and gait and reducing spasticity</p>
            </list-item>
            <list-item>
              <p>Assistive walking devices and ankle-foot orthotics</p>
            </list-item>
            <list-item>
              <p>Drugs to reduce muscle spasticity (e.g., baclofen [oral or intrathecal], tolperison; Botox<sup>&#x000ae;</sup> injections) and urinary urgency (e.g., oxybutynin)</p>
            </list-item>
          </list>
          <p><bold>Visual impairment.</bold> Low vision aids such as magnifiers may facilitate reading for individuals with reduced central acuity.</p>
          <p>In the US, publicly funded agencies for the visually impaired at the state level provide services for the blind or those with progressive eye disorders; services include vocational training, mobility training, and skills for independent living.</p>
          <p><bold>Hypothyroidism.</bold> Hypothyroidism is treated with thyroid hormone replacement (e.g., levothyroxine) at the time of diagnosis. Thyroid hormone levels should be normalized by replacement therapy and monitored by an endocrinologist.</p>
          <p><bold>Growth hormone deficiency.</bold> Growth hormone deficiency is treated with hormone replacement therapy and monitored by an endocrinologist.</p>
          <p><bold>Hypogonadism.</bold> Hypogonadotropic hypogonadism is treated with hormone replacement therapy, often including gonadotropins, at the expected time of puberty. (See <related-object link-type="booklink" source-id="gene" document-id="kms" document-type="chapter">Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency</related-object>) for more details about treatment.)</p>
        </sec>
        <sec id="pnpla6-dis.Prevention_of_Secondary_Compl">
          <title>Prevention of Secondary Complications</title>
          <p>Daily physical therapy is recommended to maintain and improve coordination, muscle strength, and gait; reduce spasticity; and prevent contractures.</p>
        </sec>
        <sec id="pnpla6-dis.Surveillance">
          <title>Surveillance</title>
          <p>Patients should be evaluated periodically (annually or as needed) by a neurologist, ophthalmologist and, if necessary, endocrinologist to assess progression and develop treatment strategies.</p>
        </sec>
        <sec id="pnpla6-dis.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Avoid the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Alcohol</p>
            </list-item>
            <list-item>
              <p>Obesity</p>
            </list-item>
            <list-item>
              <p>Inactive, sedentary lifestyle</p>
            </list-item>
            <list-item>
              <p>Exposure to medications or chemicals that exacerbate neuropathy. See <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="cmt_and_medications.pdf" content-type="local-data">Medications Potentially Toxic to Persons with CMT (or Related) Neuropathy</inline-supplementary-material> (pdf) for an up-to-date list.</p>
            </list-item>
          </list>
        </sec>
        <sec id="pnpla6-dis.Evaluation_of_Relatives_at_Ri">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="pnpla6-dis.Related_Genetic_Counseling_Is">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="pnpla6-dis.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Anecdotally, ataxia may sometimes appear for the first time or worsen during pregnancy. Note: While some individuals with ataxia report a worsening of coordination after general anesthesia, no increased risk has been reported specifically with obstetric anesthesia.</p>
          <p>Spasticity generally does not change significantly with pregnancy.</p>
        </sec>
        <sec id="pnpla6-dis.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="pnpla6-dis.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="pnpla6-dis.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">PNPLA6</italic>-related disorders are inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="pnpla6-dis.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected individual are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">PNPLA6</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Although affected sibs usually share most of the same <italic toggle="yes">PNPLA6</italic>-related phenotypic features, some features may be missing or additionally present. For example, within the same family, one sib may have all features of Boucher-Neuh&#x000e4;user syndrome and another sib may have either spastic ataxia with hypogonadism or chorioretinal dystrophy, but not both. The degree and progression of impairment may also differ between sibs.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier is 2/3.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with a <italic toggle="yes">PNPLA6</italic>-related disorder are obligate heterozygotes (carriers of a pathogenic variant in <italic toggle="yes">PNPLA6</italic>).</p>
          <p><bold>Other family members.</bold> Each sib of the proband&#x02019;s parents is at a 50% risk of being a carrier.</p>
        </sec>
        <sec id="pnpla6-dis.Heterozygote_Carrier_Detectio">
          <title>Heterozygote (Carrier) Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">PNPLA6</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="pnpla6-dis.Related_Genetic_Counseling_Is">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="pnpla6-dis.Prenatal_Testing_and_Preimpla">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">PNPLA6</italic> pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for a <italic toggle="yes">PNPLA6</italic>-related disorder are possible. However, given the possibility of intrafamilial variability, the results of such testing do not necessarily predict the phenotype, age of onset, and/or severity of findings.</p>
          <p>Prenatal testing requests vary in frequency for conditions which (like <italic toggle="yes">PNPLA6</italic>-related disorders) have no disease-modifying treatment and can present with a wide spectrum of phenotypic features. Requests may be more common in families in which affected individuals have had early-onset disease affecting many neurologic systems as well as intellect. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="pnpla6-dis.Resources">
        <title>Resources</title>
      </sec>
      <sec id="pnpla6-dis.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">PNPLA6</italic> comprises 34 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="pnpla6-dis" object-id="pnpla6-dis.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> The large majority of <italic toggle="yes">PNPLA6</italic> pathogenic variants identified to date cluster within a short stretch of about 300 nucleotides that encode the roughly 100 residues in the functionally critical EST domain [<xref ref-type="bibr" rid="pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</xref>].</p>
        <p>Several reported <italic toggle="yes">PNPLA6</italic> pathogenic variants are located in the region encoding the CNB1 and CNB2 domains (e.g., c.787G&#x0003e;A and c.1732G&#x0003e;T). These and other variants in the CNB domains likely compromise the ability of one or both regulatory CNB1/2 domains to bind cyclic nucleotide-monophosphate binding domains (cNMPs); thus, their failure to undergo a conformational change in response to changes in intracellular concentration of cNMPs would keep the esterase (EST) domain in an auto-inhibited state [<xref ref-type="bibr" rid="pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.kmoch.2015.5614">Kmoch et al 2015</xref>].</p>
        <table-wrap id="pnpla6-dis.T.pnpla6_pathogenic_variants" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p><italic toggle="yes">PNPLA6</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_pnpla6-dis.T.pnpla6_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_pnpla6-dis.T.pnpla6_pathogenic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_pnpla6-dis.T.pnpla6_pathogenic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_pnpla6-dis.T.pnpla6_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.787G&#x0003e;A</td>
                <td headers="hd_h_pnpla6-dis.T.pnpla6_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val263Ile</td>
                <td headers="hd_h_pnpla6-dis.T.pnpla6_pathogenic_variants_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_001166111.1">NM_001166111.1</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_001159583.1">NP_001159583.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_pnpla6-dis.T.pnpla6_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1732G&#x0003e;T</td>
                <td headers="hd_h_pnpla6-dis.T.pnpla6_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly578Trp</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold>
<italic toggle="yes">PNPLA6</italic> encodes the neuropathy target esterase, which belongs to a protein family of nine patatin-like phospholipase domain-containing proteins. Apart from its phospholipid esterase domain (EST; also sometimes called &#x0201c;patatin domain&#x0201d;), the modular architecture of PNPLA6 protein contains three CNB domains (CNB1, CNB2, CNB3).</p>
        <p>The most important functional domain is the EST domain, which de-esterifies phosphatidylcholine (a major component of biologic membranes) into its constituent fatty acids and glycerophosphocholine [<xref ref-type="bibr" rid="pnpla6-dis.REF.strickland.1995.667">Strickland et al 1995</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.atkins.2002.119">Atkins et al 2002</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.van_tienhoven.2002.20942">van Tienhoven et al 2002</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.zaccheo.2004.24024">Zaccheo et al 2004</xref>]. Glycerophosphocholine serves as a precursor for the biosynthesis of acetylcholine, a key neurotransmitter involved in mediating cellular signaling in the nervous system. Moreover, it has been suggested that the EST domain has a role in lysophospholipase activity [<xref ref-type="bibr" rid="pnpla6-dis.REF.van_tienhoven.2002.20942">van Tienhoven et al 2002</xref>] and functions in lipid membrane metabolism [<xref ref-type="bibr" rid="pnpla6-dis.REF.tesson.2012.1051">Tesson et al 2012</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Current knowledge suggests that <italic toggle="yes">PNPLA6</italic> pathogenic variants cause disease by impairing the capacity of the EST domain to perform ONE of two functions:</p>
        <list list-type="bullet">
          <list-item>
            <p>De-esterify phosphatidylcholine into fatty acids and glycerophosphocholine (The lack of adequate glycerophosphocholine may disturb development and maintenance of synaptic connections in a variety of neuronal networks.)</p>
          </list-item>
          <list-item>
            <p>Catalyze 2-arachidonoyl lysophosphatidylinositol, thus disturbing the metabolism of lipid membranes [<xref ref-type="bibr" rid="pnpla6-dis.REF.synofzik.2014a.69">Synofzik et al 2014a</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.hufnagel.2015.85">Hufnagel et al 2015</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.kmoch.2015.5614">Kmoch et al 2015</xref>]</p>
          </list-item>
        </list>
        <p>The EST domain is altered not only by mutation but also by the toxic effects of organophosphorous compounds [<xref ref-type="bibr" rid="pnpla6-dis.REF.rainier.2008.780">Rainier et al 2008</xref>, <xref ref-type="bibr" rid="pnpla6-dis.REF.richardson.2013.238">Richardson et al 2013</xref>] that are used in industry, agriculture, suicide attempts, chemical warfare, terrorist incidents (1995 Tokyo subway incident), and modification of alcoholic beverages (Jamaica &#x02018;Ginger Jake&#x02019; during the Prohibition era) [<xref ref-type="bibr" rid="pnpla6-dis.REF.richardson.2013.238">Richardson et al 2013</xref>].</p>
      </sec>
      <sec id="pnpla6-dis.References">
        <title>References</title>
        <sec id="pnpla6-dis.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="pnpla6-dis.Literature_Cited.reflist0">
            <ref id="pnpla6-dis.REF.atkins.2002.119">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Atkins</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luthjens</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hom</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glynn</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Monomers of the catalytic domain of human neuropathy target esterase are active in the presence of phospholipid.</article-title>
                <source>Biochem J.</source>
                <volume>361</volume>
                <fpage>119</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">11742536</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.boucher.1969.507">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boucher</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibberd</surname>
                    <given-names>FB</given-names>
                  </name>
                </person-group>
                <article-title>Familial ataxia, hypogonadism and retinal degeneration.</article-title>
                <source>Acta Neurol Scand.</source>
                <year>1969</year>
                <volume>45</volume>
                <fpage>507</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">5806782</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.daoud.2013.194">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Daoud</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tetreault</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrero</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gburek-Augustat</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Synofzik</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brais</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevens</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanchez-Carpintero</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goizet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naidu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanderver</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Mutations in POLR3A and POLR3B are a major cause of hypomyelinating leukodystrophies with or without dental abnormalities and/or hypogonadotropic hypogonadism.</article-title>
                <source>J Med Genet</source>
                <volume>50</volume>
                <fpage>194</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">23355746</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.deik.2014.2411">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Deik</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johannes</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rucker</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000e1;nchez</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brodie</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deegan</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Landy</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kajiwara</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scelsa</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saunders-Pullman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pais&#x000e1;n-Ruiz</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Compound heterozygous PNPLA6 mutations cause Boucher-Neuh&#x000e4;user syndrome with late-onset ataxia.</article-title>
                <source>J Neurol.</source>
                <year>2014</year>
                <volume>261</volume>
                <fpage>2411</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">25267340</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.fonteyn.2014.251">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fonteyn</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keus</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verstappen</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schols</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Groot</surname>
                    <given-names>IJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van De Warrenburg</surname>
                    <given-names>BP</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>The effectiveness of allied health care in patients with ataxia: a systematic review.</article-title>
                <source>J Neurol</source>
                <volume>261</volume>
                <fpage>251</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">23589192</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.holmes.1907.466">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Holmes</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1907</year>
                <article-title>A form of familial degeneration of the cerebellum.</article-title>
                <source>Brain</source>
                <volume>30</volume>
                <fpage>466</fpage>
                <lpage>89</lpage>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.hufnagel.2015.85">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hufnagel</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arno</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hein</surname>
                    <given-names>ND</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hersheson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prasad</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krueger</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gregory</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaworek</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hull</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plagnol</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willen</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prows</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hegde</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riazuddin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grabowski</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richardson</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dieterich</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Revesz</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez-Barbera</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sisk</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jefferies</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houlden</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dattani</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fink</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dollfus</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmed</surname>
                    <given-names>ZM</given-names>
                  </name>
                </person-group>
                <article-title>Neuropathy target esterase impairments cause Oliver-McFarlane and Laurence-Moon syndromes.</article-title>
                <source>J Med Genet</source>
                <year>2015</year>
                <volume>52</volume>
                <fpage>85</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">25480986</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.ilg.2014.248">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ilg</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bastian</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boesch</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burciu</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Celnik</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claassen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feil</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalla</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyai</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nachbauer</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schols</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strupp</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Synofzik</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teufel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmann</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Consensus paper: management of degenerative cerebellar disorders.</article-title>
                <source>Cerebellum</source>
                <volume>13</volume>
                <fpage>248</fpage>
                <lpage>68</lpage>
                <pub-id pub-id-type="pmid">24222635</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.ilg.2010.2239">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ilg</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brotz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burkard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giese</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schols</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Synofzik</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Long-term effects of coordinative training in degenerative cerebellar disease.</article-title>
                <source>Mov Disord</source>
                <volume>25</volume>
                <fpage>2239</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">20737551</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.ilg.2012.2056">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ilg</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schatton</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schicks</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giese</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schols</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Synofzik</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Video game-based coordinative training improves ataxia in children with degenerative ataxia.</article-title>
                <source>Neurology</source>
                <volume>79</volume>
                <fpage>2056</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">23115212</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.ilg.2009.1823">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ilg</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Synofzik</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brotz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burkard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giese</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schols</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Intensive coordinative training improves motor performance in degenerative cerebellar disease.</article-title>
                <source>Neurology</source>
                <volume>73</volume>
                <fpage>1823</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">19864636</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.kmoch.2015.5614">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kmoch</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majewski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramamurthy</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cao</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fahiminiya</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ren</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>IM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keser</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Str&#x000e1;neck&#x000fd;</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartmannov&#x000e1;</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x00159;istoupilov&#x000e1;</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoda&#x00148;ov&#x000e1;</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piherov&#x000e1;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kucha&#x00159;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baxov&#x000e1;</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barsottini</surname>
                    <given-names>OG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pyle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffin</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Splitt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sallum</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolmie</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sampson</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Care4Rare Canada, Banin E, Sharon D, Dutta S, Grebler R, Helfrich-Foerster C, Pedroso JL, Kretzschmar D, Cayouette M, Koenekoop RK. Mutations in PNPLA6 are linked to photoreceptor degeneration and various forms of childhood blindness.</article-title>
                <source>Nat Commun.</source>
                <year>2015</year>
                <volume>6</volume>
                <fpage>5614</fpage>
                <pub-id pub-id-type="pmid">25574898</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.krieger.2013.3634">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Krieger</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roos</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stendel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claeys</surname>
                    <given-names>KG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sonmez</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baudis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bornemann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Goede</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dufke</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finkel</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goebel</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haussler</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kingston</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirschner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Medne</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muschke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rivier</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudnik-Schoneborn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spengler</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inzana</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stanzial</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benedicenti</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Synofzik</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lia Taratuto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pirra</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tay</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topaloglu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uyanik</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wand</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zerres</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senderek</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>SIL1 mutations and clinical spectrum in patients with Marinesco-Sjogren syndrome.</article-title>
                <source>Brain</source>
                <volume>136</volume>
                <fpage>3634</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">24176978</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.margolin.2013.1992">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Margolin</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kousi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>YM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>ET</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmahmann</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hadjivassiliou</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adam</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dwyer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plummer</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aldrin</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'rourke</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirby</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lage</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milunsky</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milunsky</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hedley-Whyte</surname>
                    <given-names>ET</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daly</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katsanis</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seminara</surname>
                    <given-names>SB</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination.</article-title>
                <source>N Engl J Med</source>
                <volume>368</volume>
                <fpage>1992</fpage>
                <lpage>2003</lpage>
                <pub-id pub-id-type="pmid">23656588</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.rainier.2011.19">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rainier</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albers</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dyck</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eldevik</surname>
                    <given-names>OP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcock</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richardson</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fink</surname>
                    <given-names>JK</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Motor neuron disease due to neuropathy target esterase gene mutation: clinical features of the index families.</article-title>
                <source>Muscle Nerve</source>
                <volume>43</volume>
                <fpage>19</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">21171093</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.rainier.2008.780">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rainier</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bui</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mark</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tokarz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ming</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delaney</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richardson</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albers</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsunami</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevens</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coon</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leppert</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fink</surname>
                    <given-names>JK</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Neuropathy target esterase gene mutations cause motor neuron disease.</article-title>
                <source>Am J Hum Genet</source>
                <volume>82</volume>
                <fpage>780</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">18313024</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.richardson.2013.238">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Richardson</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hein</surname>
                    <given-names>ND</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wijeyesakere</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fink</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Makhaeva</surname>
                    <given-names>GF</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Neuropathy target esterase (NTE): overview and future.</article-title>
                <source>Chem Biol Interact</source>
                <volume>203</volume>
                <fpage>238</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">23220002</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.sapir.2003.387">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sapir</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spielman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramig</surname>
                    <given-names>LO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hinds</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Countryman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Story</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on ataxic dysarthria: a case study.</article-title>
                <source>Am J Speech Lang Pathol</source>
                <volume>12</volume>
                <fpage>387</fpage>
                <lpage>99</lpage>
                <pub-id pub-id-type="pmid">14658991</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.shi.2014.1013">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shi</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schisler</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubel</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mcdonough</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Portbury</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mao</surname>
                    <given-names>CY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>True</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>QZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seminara</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patterson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>YM</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Ataxia and hypogonadism caused by the loss of ubiquitin ligase activity of the U box protein CHIP.</article-title>
                <source>Hum Mol Genet</source>
                <volume>23</volume>
                <fpage>1013</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">24113144</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.strickland.1995.667">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Strickland</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orr</surname>
                    <given-names>GL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>TA</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Inhibition of diabrotica larval growth by patatin, the lipid acyl hydrolase from potato tubers.</article-title>
                <source>Plant Physiol</source>
                <volume>109</volume>
                <fpage>667</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">12228621</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.synofzik.2013a.e145">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Synofzik</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindig</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gburek-Augustat</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2013a</year>
                <article-title>Teaching neuroimages: hypomyelinating leukodystrophy with hypodontia due to POLR3B: Look into a leukodystrophy's mouth.</article-title>
                <source>Neurology</source>
                <volume>81</volume>
                <fpage>e145</fpage>
                <pub-id pub-id-type="pmid">24190003</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.synofzik.2014a.69">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Synofzik</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzalez</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lourenco</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coutelier</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haack</surname>
                    <given-names>TB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rebelo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hannequin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strom</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prokisch</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kernstock</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durr</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schols</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lima-Martinez</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farooq</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schule</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevanin</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marques</surname>
                    <given-names>W</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Zuchner</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2014a</year>
                <article-title>PNPLA6 mutations cause Boucher-Neuhauser and Gordon Holmes syndromes as part of a broad neurodegenerative spectrum.</article-title>
                <source>Brain</source>
                <volume>137</volume>
                <fpage>69</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">24355708</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.synofzik.2014">
              <mixed-citation publication-type="other">Synofzik M, Ilg W. Motor training in degenerative spinocerebellar disease: ataxia-specific improvements by intensive physiotherapy and exergames. Biomed Res Int. 2014;2014:583507.</mixed-citation>
            </ref>
            <ref id="pnpla6-dis.REF.synofzik.2015.580">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Synofzik</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kernstock</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haack</surname>
                    <given-names>TB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000f6;ls</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Ataxia meets chorioretinal dystrophy and hypogonadism: Boucher-Neuh&#x000e4;user syndrome due to PNPLA6 mutations.</article-title>
                <source>J Neurol Neurosurg Psychiatry.</source>
                <year>2015</year>
                <volume>86</volume>
                <fpage>580</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">24790214</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.synofzik.2013b.2656">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Synofzik</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schatton</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giese</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolf</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schols</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ilg</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2013b</year>
                <article-title>Videogame-based coordinative training can improve advanced, multisystemic early-onset ataxia.</article-title>
                <source>J Neurol</source>
                <volume>260</volume>
                <fpage>2656</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">23989345</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.synofzik.2014b.57">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Synofzik</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000fc;le</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulze</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gburek-Augustat</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schweizer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schirmacher</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kr&#x000e4;geloh-Mann</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzalez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Z&#x000fc;chner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000f6;ls</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauer</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Phenotype and frequency of STUB1 mutations: next-generation screenings in Caucasian ataxia and spastic paraplegia cohorts.</article-title>
                <source>Orphanet J Rare Dis.</source>
                <year>2014b</year>
                <volume>9</volume>
                <fpage>57</fpage>
                <pub-id pub-id-type="pmid">24742043</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.tarnutzer.2015.194">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tarnutzer</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerth-Kahlert</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmann</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>DI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harmuth</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straumann</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Synofzik</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Boucher-Neuhauser syndrome: cerebellar degeneration, chorioretinal dystrophy and hypogonadotropic hypogonadism: two novel cases and a review of 40 cases from the literature.</article-title>
                <source>J Neurol</source>
                <volume>262</volume>
                <fpage>194</fpage>
                <lpage>202</lpage>
                <pub-id pub-id-type="pmid">25359264</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.tesson.2012.1051">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tesson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nawara</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salih</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossignol</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zaki</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al Balwi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schule</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mignot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Obre</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouhouche</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santorelli</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durand</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oteyza</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El-Hachimi</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al Drees</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouslam</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamari</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elmalik</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kabiraj</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seidahmed</surname>
                    <given-names>MZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Esteves</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaussen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monin</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gyapay</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lechner</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzalez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Depienne</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mochel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lavie</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schols</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacombe</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yahyaoui</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al Abdulkareem</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuchner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamashita</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benomar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goizet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durr</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gleeson</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darios</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevanin</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia.</article-title>
                <source>Am J Hum Genet</source>
                <volume>91</volume>
                <fpage>1051</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">23176821</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.van_tienhoven.2002.20942">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Tienhoven</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atkins</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glynn</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Human neuropathy target esterase catalyzes hydrolysis of membrane lipids.</article-title>
                <source>J Biol Chem</source>
                <volume>277</volume>
                <fpage>20942</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11927584</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.yoon.2013.181">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yoon</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baskin</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tarnopolsky</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boycott</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geraghty</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sell</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goobie</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meschino</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banwell</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ray</surname>
                    <given-names>PN</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Autosomal recessive hereditary spastic paraplegia-clinical and genetic characteristics of a well-defined cohort.</article-title>
                <source>Neurogenetics</source>
                <volume>14</volume>
                <fpage>181</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">23733235</pub-id>
              </element-citation>
            </ref>
            <ref id="pnpla6-dis.REF.zaccheo.2004.24024">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zaccheo</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dinsdale</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meacock</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glynn</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Neuropathy target esterase and its yeast homologue degrade phosphatidylcholine to glycerophosphocholine in living cells.</article-title>
                <source>J Biol Chem</source>
                <volume>279</volume>
                <fpage>24024</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">15044461</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="pnpla6-dis.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="pnpla6-dis.Acknowledgments">
          <title>Acknowledgments</title>
          <p>This work was supported by the Interdisciplinary Center for Clinical Research IZKF T&#x000fc;bingen (Grant 2191-0-0 to MS), U54NS0657, R01NS075764, R01NS072248, the MDA, and the CMT Association.</p>
        </sec>
        <sec id="pnpla6-dis.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>11 June 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>9 October 2014 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>29 May 2014 (ms) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
